reflexes, the alpha activity in the EEG slowed to 8 Hz and maintained the frontal distribution but attenuated for short periods in response to stimulation. Forty-eight hours after admission the patient was alert. The final EEG performed three weeks later as an outpatient showed normally reactive 10 Hz alpha activity in a posterior distribution.
The other three patients were all receiving chlormethiazole for alcohol withdrawal states. Two had generalised seizures, and all three were treated with thiamine and diazepam, and one with phenytoin and phenobarbitone. Each of the three had biochemical evidence of hepatic dysfunction, and one had mild transient hyperammonaemia. Two became comatose and one stuporous shortly after starting high doses of chlormethiazole. The initial EEGs of all three patients showed generalised or predominantly frontal alpha or slow beta activity, which did not react to the usual alerting stimuli. In the two comatose patients the activity was in the 11-12 Hz frequency range in one (see figure) and in the 12-14 Hz range in the other. The third patient, who also received phenytoin and phenobarbitone, showed frontally predominant 14-16 Hz beta activity. Withdrawal of the chlormethiazole was accompanied by a return to normal consciousness with normally reactive posterior alpha activity and beta frequencies in the EEG in each case.
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Name coiled
Generalised non-reactive 11-12 Hz alpha activity in EEG of comatose 54-year-old man after chlormethiazole administration for alcohol withdrawal.
Comment
Alpha coma has usually carried a poor prognosis despite a recent report by Grindal et a13 of nine survivors from a series of 24 cases. Although generalised beta activity is well recognised in certain forms of drug-induced coma,4 and has also been reported in non-comatose patients receiving chlormethiazole for alcohol withdrawal,5 to our knowledge alpha coma has not been described in association with benzodiazepine or chlormethiazole intoxication.
The present cases raise several points of practical importance. Firstly, the finding of diffuse or frontally predominant non-reactive alpha activity in the EEG of a patient in coma does not necessarily indicate structural brain disease but should also suggest a possible pharmacological cause. Secondly, the observation of this type of EEG pattern in patients with profound drug-induced coma need not imply that secondary hypoxic brain damage has occurred. Finally, the present cases illustrate the variability of the EEG changes produced by chlormethiazole when used with other drugs during alcohol withdrawal.
We conclude that when the EEG shows the dominant activity to be in the alpha and beta range of frequencies in patients in coma due to drug intoxication, uncomplicated by appreciable cerebral hypoxia, a favourable outcome is to be expected.
1 Loeb, C, Rossadini, G, and Poggio, G F, Neurology, 1959, 9, 610. 2 Westmoreland, B F, et al, Archives of Neurology, 1975, 32, 713. 3 Grindal, A B, Suter, C, and Martinez, A J, Annals of Neurology, 1977 , 1, 371. 4Konigshausen, Th, and Rabe, F, Medical World, 1975 , 26, 1655 . 5 Bergener, M, Acta Psychiatrica Scandinavica, 1966 The beneficial effect of amiodarone in atrial fibrillation and on conduction in anomalous pathways is related to the prolongation of action potential and refractory period of the myocardium. The drug is cumulative with a slow rate of elimination.4 The onset of action is slow and persists for weeks after dosage has ended.3 These properties explain the continued success of amiodarone in our case when dosage was reduced to 200 mg on alternate days. Microdeposits occur in the corneae5 but, in the dosage used to control arrhythmias, rarely cause symptoms: and are reversible. The drug has not yet been licensed in Britain by the Medicines Commission.
In this case amiodarone produced a dramatic and life-saving effect, restoring a severely incapacitated man to excellent health after the reversion of previously refractory atrial fibrillation to sinus rhythm. The degree of hyperuricaemia is widely used as a prognostic index in pre-eclampsia.' Nevertheless, the reliability of the random blood sample conventionally used for this has not been adequately assessed during pregnancy, despite evidence in non-pregnant women of considerable variation from day to day and within any given day.24 We therefore decided to examine changes in serum urate concentration in normal pregnant women throughout a 24-hour period.
Patients, methods, and results
Fourteen normotensive inpatients were studied without restriction of diet or activity throughout 24 hours during the third trimester of pregnancy. One patient (case 3) was carrying twins. No patient was taking medication known to affect the serum urate concentration. Venous blood samples were withdrawn at 0600, 1000, 1400, 1800, and 2200 on day 1 and at 0600 the next morning. Serum was analysed on the day of collection, or snap-frozen in liquid nitrogen and stored at -20 C for not more than three weeks. This procedure had been validated,' and its reliability was confirmed in our laboratory. Duplicate samples were analysed manually by an enzymatic method based on a commercial reagent pack (Uricaquant). The mean error of the method was ± 1 5 ,.
The interpatient variability was much greater than the intersample variability in any patient (see table) . The overall mean and the standard deviation within samples within patients showed that the variability among random samples was small, but a range of up to 30 ,0 was found in some women. No consistent pattern of variation emerged, but there were significant differences between certain of the time points. A longer study, however, would be needed to validate these differences.
Comment
The results suggest that pregnant women have considerable fluctuations of serum urate during the day. Despite a tendency towards lower concentrations during daylight hours, no single reading would be representative for any individual. These results agree with published data in non-pregnant women.
Furthermore, serum urate concentration does not appear to remain stable from day to day; comparison of samples taken 24 hours apart again shows considerable variation within individuals. In the data presented the second of the results is lower than the first in most cases. This unexpected pattern has not been confirmed in subsequent studies.
Intersample variability is itself of different magnitude from patient to patient, so that it would not be reasonable to predict the accuracy of a given result on the basis of the concentration of urate reported. Thus a single blood sample in the individual case may not truly represent the mean value for that patient throughout the day. This is particularly relevant to the popular practice of screening pregnant women for hyperuricaemia at a routine antenatal visit.
The cause of this diurnal variation remains unexplained. The overall pattern does not suggest a relation between urate and purine ingestion at meals. One factor may be an alteration in urate excretion, and this is being investigated.
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